Myosin-X, a novel myosin with pleckstrin homology domains, associates with regions of dynamic actin by unknown
INTRODUCTION
Myosins are actin-based motor proteins that provide the
molecular basis for many cellular movements. In addition to
the conventional (class II) myosins required for processes such
as muscle contraction, cells also express several classes of
unconventional myosins. These proteins have motor domains
similar to those of the conventional myosins but have tail
domains that are structurally unique and confer class specific
functions (Mooseker and Cheney, 1995). The physiological
importance of myosins has been underscored by the discovery
that mutations of these motors can lead to severe phenotypes
such as cardiomyopathy, deafness, seizures, and death (Oliver
et al., 1999; Sellers, 2000). Thus, each class of myosins appears
to be associated with a conserved set of fundamental functions
such as contractile filament formation for class II myosins or
organelle transport for class V myosins.
We have identified myosin-X, a new member of the myosin
superfamily. A partial sequence from the head domain of
myosin-X was initially discovered in a PCR screen to identify
novel myosins that might be involved in sensory transduction
in bullfrog (Solc et al., 1994) and preliminary phylogenetic
analysis of the head domain sequence (Mooseker and Cheney,
1995) indicated that it did not fall into any of the known myosin
classes. To begin to investigate the structure and function of
this putative motor protein, we have now obtained the full-
length sequences of bovine and human myosin-X. These
sequences constitute a novel class of myosins whose unique
tail domain structure includes multiple pleckstrin homology
(PH) domains, first identified as ~100 aa modules similar to
the N-terminal and C-terminal domains of pleckstrin (Haslam
et al., 1993; Mayer et al., 1993). PH domains exhibit only
modest protein sequence similarity but fold into a conserved
3-D structure and are found primarily in proteins involved
in signal transduction pathways or cytoskeletal function
(Lemmon et al., 1996). The PH domains of myosin-X thus
raise the possibility of a mechanism by which this novel motor
could act as a mobile link between the actin cytoskeleton and
numerous signal transduction pathways.
In addition to actin-based motility, unconventional myosins
e now known to have roles in signal transduction (Bahler,
2000; Baker and Titus, 1998; Hasson and Mooseker, 1997;
Mermall et al., 1998). For example, DrosophilaninaC (a class
III myosin) is a component of the transducisome, a multi-
protein signaling complex required for phototransduction in
the Drosophila rhabdomere (Li et al., 1998), while class IX
myosins possess GTPase activating protein activity for Rho
(Muller et al., 1997; Post et al., 1998). Strikingly, class I
myosins were recently found to be involved in actin nucleation
b  the Arp2/3 complex via interactions with the WASP family
of proteins (Evangelista et al., 2000; Lechler et al., 2000).
These unconventional myosins thus demonstrate the potential
for direct connections between actin-based motors and a
variety of signal transduction cascades.
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Myosin-X is the founding member of a novel class of
unconventional myosins characterized by a tail domain
containing multiple pleckstrin homology domains. We
report here the full-length cDNA sequences of human and
bovine myosin-X as well as the first characterization of this
protein’s distribution and biochemical properties. The 235
kDa myosin-X contains a head domain with <45% protein
sequence identity to other myosins, three IQ motifs, and
a predicted stalk of coiled coil. Like several other
unconventional myosins and a plant kinesin, myosin-X
contains both a myosin tail homology 4 (MyTH4) domain
and a FERM (band 4.1/ezrin/radixin/moesin) domain. The
unique tail domain also includes three pleckstrin
homology domains, which have been implicated in
phosphatidylinositol phospholipid signaling, and three
PEST sites, which may allow cleavage of the myosin tail.
Most intriguingly, myosin-X in cultured cells is present at
the edges of lamellipodia, membrane ruffles, and the tips
of filopodial actin bundles. The tail domain structure,
biochemical features, and localization of myosin-X suggest
that this novel unconventional myosin plays a role in
regions of dynamic actin.
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Although myosin-X is the founding member of a novel class
of myosins, virtually nothing is known about the protein or its
function. In this paper we propose a model for the molecular
structure of myosin-X and report that it is widely but not
abundantly expressed in vertebrate tissues. We present
biochemical evidence that myosin-X may associate with actin
and cell membranes. We demonstrate that, intriguingly,
myosin-X protein is a component of lamellipodia, membrane
ruffles, and filopodia. These regions of dynamic actin are
widely recognized as substrates for a variety of modes of cell
motility, and their structure and regulation is of great interest.
The tail domain structure, biochemistry, and localization of
myosin-X thus lead us to propose that myosin-X serves as a
link between membrane signaling and the actin cytoskeleton.
MATERIALS AND METHODS
Isolation, sequencing and analysis of myosin-X cDNAs
A random-primed bovine aorta cDNA library (Lambda Zap, a gift
from Dr Tom Michel) and an oligo-dT primed bovine aorta library
were hybridization screened using a bullfrog myosin-X PCR fragment
(Solc et al., 1994). Plaques that were positive following a tertiary
screen were rescued by in vivo excision, and the entire cDNA was
sequenced at least threefold. To obtain the human myosin-X cDNA,
a human heart cDNA library (oligo-dT and random-primed) was
hybridization screened, resulting in a clone of approx. 920 bp at the
5′ end of the human myosin-X cDNA. PCR primers to the 3′ nd of
this clone and to the 5′ end of the partial cDNA KIAA0799 were used
to amplify the intervening sequence using human kidney Marathon-
Ready cDNA (Clontech). The resulting approx. 3.3 kb product was
sequenced directly and then assembled into a new contig with the
previously obtained 5′ clone and KIAA0799. Sequence analysis was
performed using the PC/GENE v6.01 (Intelligenetics) and Genetics
Computer Group (GCG; Devereux et al., 1984) packages and web-
based tools such as Pfam (Bateman et al., 2000) and PESTFIND
(Rechsteiner and Rogers, 1996).
RNA analysis
The cDNA used to probe human multiple tissue northern and master
blots (Clontech) was generated by PCR (Forward primer: 5′-
CACGAGGCGAATACGTATAAGATCG – 3′; Reverse primer: 5′-
CTAAAACCAGCACTGGAGCCAGCTG – 3′) from an expressed
sequence tag (EST) corresponding to 150 nucleotides of coding
sequence and 850 nucleotides of 3′ untranslated sequence of human
myosin-X (GenBank accession # W16936). The probe was labeled by
random priming (Boehringer Mannheim), unincorporated counts were
removed (ProbeQuant G-50 Micro Columns, Pharmacia Biotech), and
probe was added to the hybridization solution to a final concentration
of 2-4×106 cpm/ml. The blots were hybridized and washed using
stringent conditions. Autoradiographs were scanned and adjusted for
brightness and contrast using Adobe Photoshop. 
In situ hybridizations were carried out using frozen sections of
mouse brain and testis. Sense and antisense probes spanning
nucleotides 4582-4978 of the bovine sequence were labeled with
digoxignenin-UTP by T7 and T3 RNA polymerase reactions from a
fragment of mouse myosin-X cDNA cloned into pBSK (Stratagene).
The sections were hybridized and washed under stringent conditions
and developed using reagents from Boehringer Mannheim (100 mM
Tris, pH 9.5, 100 mM NaCl, 0.1% Tween-20, 10% polyvinyl alcohol,
50 mM MgCl2, 5 mM levamisol, 0.45% NBT, 0.35% BCIP). 
Antibodies
For biochemical studies and immunolocalization, antibodies were
raised from two different fragments of bovine myosin-X. The antigen
used for myosin-X head antibodies was a baculovirus-expressed
head/neck/coiled coil fragment including aa 1-952 of bovine myosin-
X with the point mutation M747T and an 8 aa FLAG tag at the
carboxyl terminus, which was used to immunize a rabbit by Covance
Labs (Head Ab 117). The antigen used for myosin-X tail antibodies
was a bacterially expressed fusion protein consisting of aa 1639-1798
of bovine myosin-X cloned into pGEX-3X (Pharmacia) with
glutathione-S-transferase (GST) attached to the amino terminus of the
myosin-X sequence. The fusion protein was solubilized in sarkosyl
and purified on glutathione beads (Frangioni and Neel, 1993), then
used to generate IgY antibodies in chicken serum by East-Acres
Biologicals (Tail Ab 1071). Antibodies were purified on affinity
columns (Harlow and Lane, 1988) using the fusion proteins against
which they were generated, and the tail antibody was affinity depleted
to remove immunoreactivity against GST. Non-muscle myosin-IIa
polyclonal antibody (BT-561) was purchased from Biomedical
Technologies Inc.
Immunoblots
To assess the specificity of the myosin-X antibodies, bovine tissues
were acquired from a slaughterhouse and either frozen immediately
in liquid nitrogen or stored on ice until homogenized. Samples of
bovine tissue were homogenized at 1 g wet weight/10 ml in buffer
containing 40 mM HEPES, 10 mM EDTA, 2 mM DTT, 1 mM
Pefablock, 5 mM ATP, 5 µg/ml pepstatin A, pH 7.2, and immediately
boiled 5-10 minutes in SDS sample buffer. Samples were separated
on 4-20% Tris-glycine SDS-PAGE gels and transferred to
nitrocellulose at 150 V-hr in transfer buffer (25 mM Tris, 192 mM
glycine, 20% methanol, 0.02% SDS). Affinity purified antibodies
were used at 1-2 µg/ml with 1:100,000 donkey anti-rabbit (Jackson)
or 1:2500 donkey anti-chicken (Jackson) secondary. Immunoblots
were developed using SuperSignal West Pico chemiluminescent
ubstrate (Pierce) and films were scanned and adjusted for brightness
and contrast using Adobe Photoshop.
Cell culture
Madin-Darby bovine kidney (MDBK) cells were obtained from the
Lineberger Comprehensive Cancer Center, UNC-Chapel Hill. MDBK
cells were maintained in MEM medium supplemented with 10% fetal
bovine serum, 2% glutamine, and 100 U penicillin-streptomycin-
fungizone. Lysates were prepared by scraping cells in solubilization
buffer (20 mM MOPS, 75 mM KCl, 2.5 mM MgCl2, 1 mM EGTA, 1
mM DTT, 0.5 mM ATP, 1 mM Pefablock, 0.2 mM PMSF, 5 µg/ml
pepstatin, 5 µg/ml leupeptin, pH 7.4) and homogenizing on ice with
75 Dounce strokes. For immunoblotting, crude lysates were
immediately boiled in SDS. For actin cosedimentation assays,
homogenates were spun in a table-top ultracentrifuge (Beckman) at
approx. 150,000 g for 15 minutes at 4°C. The supernatant was
collected and the pellet was resuspended to the same volume. 
Biochemical experiments
For fractionation, bovine kidney was homogenized in solubilization
buffer (see above) and subjected to sequential centrifugation (1000 g
for 5 minutes, 10,000 g for 15 minutes, 100,000 g for 15 minutes).
For in vivo proteolysis, bovine kidney was homogenized in 40 mM
HEPES, 2 mM EDTA, 2 mM DTT, pH 7.7 and incubated with 2 mM
Ca2+ in the absence or presence of 0.5 units of calpain (Sigma).
Proteolysis was halted by the addition of EGTA at different time
points for analysis by immunoblotting. For actin cosedimentation
a says, f-actin was added to MDBK lysates in the absence or presence
of 0.2 units of hexokinase (Sigma) plus glucose and incubated for 15
minutes. Samples were then centrifuged at 150,000 g in a TLA100
tabletop ultracentrifuge rotor for 15 minutes at 4°C and analyzed by
immunoblotting.
Immunofluorescence
MDBK cells were plated onto acid-washed coverslips in twelve-well
J. S. Berg and others
3441Myosin-X associates with regions of dynamic actin
cell culture plates for immunofluorescence. The cells were fixed with
3.7% paraformaldehyde for 20 minutes, permeabilized with 0.5%
Triton for 10-20 minutes, and blocked in 5% goat serum for 60-90
minutes. Coverslips were incubated with specific antibodies at 5
µg/ml for 1 hour, rinsed three times for 15 minutes in PBS, incubated
with Alexa 488-conjugated goat anti-rabbit secondary antibody
(Molecular Probes) at 1 µg/ml for 45-60 minutes, and rinsed in PBS
for three 10 minute rinses, one 15 minute rinse containing rhodamine-
phalloidin at 1:500 (Molecular Probes), and a final 15 minute rinse.
Coverslips were mounted using Prolong mounting medium
(Molecular Probes) and examined using a Zeiss fluorescence
microscope equipped with a 1.4 NA ×100 objective. Images were
obtained using an Orca II cooled CCD digital camera (Hamamatsu)
and Metamorph software (Universal Imaging). Confocal images were
acquired using a Leica TCS NT system to obtain 0.5-0.7 µm z-
sections, which were combined into extended focus images using
Metamorph. All images were prepared for publication using Adobe
Photoshop.
RESULTS
Discovery of bovine and human myosin-X
Three overlapping clones encoding the ~7.8 kb bovine myosin-
X coding sequence, ~220 bp of 5′ untranslated sequence,
and ~1390 bp of 3′ untranslated sequence (Fig. 1; GenBank
accession #U55042) were obtained from an aorta cDNA library.
The region surrounding the start codon at bp 223 (ACATGG)
contains seven of eight nucleotides defined by Kozak (1986) as
being important for eukaryotic initiation, and there are stop
codons in all reading frames of the 5′ UTR. The deduced coding
sequence of bovine myosin-X is 2052 aa with a predicted
molecular mass of 235,837 Da. The domain structure of
myosin-X is depicted in bar diagram form (Fig. 1B). The 3′
UTR begins with a stop codon at bp 6379, extends to a
consensus polyadenylation initiator (bp 7753; AATAAA) and
concludes at the poly(A) tail (bp 7769).
To identify human myosin-X, we searched the GenBank
database and discovered a clone corresponding to roughly the
last half of the bovine coding region (KIAA0799; GenBank
accession #AB018342). An approximately 2 kb region within
KIAA0799 that does not match the bovine cDNA contains an
Alu repetitive sequence and is identical to intronic sequence
present in genomic sequence for the human MYO10 gene
(GenBank accession #AC010358), suggesting that the
KIAA0799 clone results from an incompletely processed
mRNA (Fig. 1D). A clone representing the 5′ end of myosin-
X was isolated from a human heart cDNA library and a PCR
product from human kidney cDNA that spanned the head and
tail fragments was identified (Fig. 1D; GenBank accession
#AF247457). Human myosin-X consists of 2058 aa with a
predicted molecular mass of 237,552 Da, and shares 93% aa
identity with bovine myosin-X (Fig. 2). Human myosin-X is
represented by over 100 ESTs in GenBank (UniGene entry
Hs.61638) and several other full-length sequences for human
myosin-X have recently been submitted to GenBank (accession
#AF234532 and AF132021/AF132022).
Preliminary intron/exon analysis for the MYO10gene was
performed using genomic clones from chromosome 5
(GenBank accession #AC010358, AC023060, and AC010607).
Based on these contigs, which encompass the entire coding
region, the MYO10gene spans >200,000 bp and is organized
into at least 41 exons (not shown). The identification of genomic
sequence from chromosome 5 coding for the human MYO10
gene confirms prior localization of myosin-X to the region of
5p15.1-14.3 (Hasson et al., 1996). Although no myosin-X
A.  Bovine myosin-X cDNA clones  
Clone 17
976                       2653
Clone 5.2.1
2030                                                                                          7769
Clone 27
1                         1564
B.  Domain Map of Bovine myosin-X
TGAATG PolyA
(nt) 223         1000         2000         3000           4000           5000          6000  6379            7769
(aa)   1                                     740      979  1150            1550        1750          2052
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D.  Human myosin-X cDNA clones
~3.3kb PCR Product
Motor IQ  CC   PEST        PH           MyTH4     FERM
Fig. 1. (A) The full length coding sequence for bovine myosin-X was
sequenced from three overlapping clones. (B) The deduced sequence
indicates that myosin-X contains a conserved motor domain and a
neck consisting of three IQ motifs (light chain-binding sites). The tail
domain contains a predicted stalk of coiled coil, three PEST regions,
three PH domains, a MyTH4 domain, and a FERM domain. (C) A
baculovirus-expressed protein fragment consisting of the motor
domain, IQ motifs, and coiled coil was used to generate specific
antibodies to the myosin-X head. A GST-fusion protein consisting of
the region between the MyTH4 and FERM domains was produced in
bacteria for generation of specific antibodies to the myosin-X tail.
(D) The full length coding sequence for human myosin-X was
determined from a partial clone identified in the GenBank database
(KIAA0799), a 920 bp clone coding for the 5′ end of the head
domain and a ~3.3 kb PCR product. The KIAA0799 clone likely
represents an incompletely processed mRNA as it includes a ~2 kb
region containing Alu repetitive sequence.
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mutations have yet been identified, Familial Chondrocalcinosis
2 maps to 5p15.1 (Rojas et al., 1999) and the genetic syndrome
known as Cri-du-chat involves variable deletions of the short
arm of chromosome 5 (Overhauser et al., 1994).
Myosin-X is widely expressed among vertebrates
A large number of mouse ESTs (UniGene entry Mm.60590)
are present in the GenBank database and a full-length mouse
yosin-X sequence (GenBank accession #AJ249706) has
recently been reported (Yonezawa et al., 2000). In addition to
the initial fragment of frog myosin-X (GenBank accession #
U14373), other partial myosin-X sequences are currently
known from ESTs of rat (GenBank accession #AI045505;
UniGene # Rn.20885) and zebrafish (Danio rerio; GenBank
J. S. Berg and others
Fig. 2.Alignment of human and bovine myosin-X protein sequence. The conserved ‘GESGAKT’ sequence within the motor domain is
indicated by dashed underline. The core portion of the IQ motifs are indicated by dashed boxes, and the region predicted to form coiled c il
structure is italicized. The three PEST regions are underlined. PH domains 1, 2 and 3 are indicated by solid boxes with one, two or thr e lines,
respectively. The MyTH4 and FERM domains are shaded in light grey and dark grey, respectively. The myosin-X sequences exhibit 93%
sequence identity overall. The sequence data for bovine and human myosin-X are available from GenBank/EMBL/DDBJ under accession #
U55042 and AF247457.
hum  MDNFFTEGTR VWLRENGQHF PSTVNSCAEG IVVFRTDYGQ VFTYKQSTIT HQKVTAMHPT NEEGVDDMAS LTELHGGSIM YNLFQRYKRN QIYTYIGSIL  100
bov  MDNFFPEGTR VWLRENGQHF PSTVNSCAEG VVVFQTDYGQ VFTYKQSTIT HQKVMPMQPT DEEGVDDMAT LTELHGGAIM HNLYQRYKRN QIYTYIGSII  100
hum  ASVNPYQPIA GLYEPATMEQ YSRRHLGELP PHIFAIANEC YRCLWKRHDN QCILISGESG AGKTESTKLI LKFLSVISQQ SLELSLKEKT SCVERAILES  200
bov  ASVNPYKTIT GLYSRDAVDR YSRCHLGELP PHVFAIANEC YRCLWKRHDN QCVLISGESG AGKTESTKLI LKFLSAISQQ SVDLSSKEKT SSVEQAILES  200
hum  SPIMEAFGNA KTVYNNNSSR FGKFVQLNIC QKGNIQGGRI VDYLLEKNRV VRQNPWERNY HIFYALLAGL EHEEREEFYL STPENYHYLN QSGCVEDKTI  300
bov  SPIMEAFGNA KTVYNNNSSR FGKFVQLNIG QKGNIQGGRI VDYLLEKNRV VRQNPGERNY HIFYALLAGL GHEEREEFYL SVPENYHYLN QSGCVTDRTI  300
hum  SDQESFREVI TAMDVMQFSK EEVWEVSRLL AGILHLGNIE FITAGGAQVS FKTALGRSAE LLGLDPTQLT DALTQRSMFL RGEEILTPLN VQQAVDSRDS  400
bov  SDQESFREVI MAMEVMQFSK EEVREVLRLL AGILHLGNIE FITAGGAQVS FKTALGRSAE LLGLDPAQLT DALTQRSMFL RGEEILTPLN VQQAADSRDS  400
hum  LAMALYACCF EWVIKKINSR IKGNEDFKSI GILDIFGFEN FEVNHFEQFN INYANEKLQE YFNKHIFSLE QLEYSREGLV WEDIDWIDNG ECLDLIEKKL  500
bov  LAMALYARCF EWVIKKINSR IKGKDDFKSI GILDIFGFEN FEVNHFEQFN INYANEKLQE YFNKHIFSLE QLEYSREGLV WEDIDWIDNG ECLDLIEKKL  500
hum  GLLALINEES HFPQATDSTL LEKLHSQHAN NHFYVKPRVA VNNFGVKHYA GEVQYDVRGI LEKNRDTFRD DLLNLLRESR FDFIYDLFEH VSSRNNQDTL  600
bov  GLLALINEES HFPQATDSTL LEKLHNQHAN NHFYVKPRVA VNNFGVKHYA GEVQYDVRGI LEKNRDTFRD DLLNLLRESR FDFIYDLFEH VSSRNNQDTL  600
hum  KCGSKHRRPT VSSQFKDSLH SLMATLSSSN PFFVRCIKPN MQKMPDQFDQ AVVLNQLRYS GMLETVRIRK AGYAVRRPFQ DFYKRYKVLM RNLALPEDVR  700
bov  KCGSKHRRPT VSSQFKDSLH SLMATLSASN PFFVRCIKPN MQKMPDQFDQ AVVVNQLRYS GMLETVRIRK AGYAVRRPFQ DFYKRYKVLM RNVALPEDIR  700
                                                            IQ1                      IQ2                      IQ3
hum  GKCTSLLQLY DASNSEWQLG KTKVFLRESL EQKLEKRREE EVSHAAMVIR AHVLGFLARK QYRKVLYCVV IIQKNYRAFL LRRRFLHLKK AAIVFQKQLR  800
bov  GKCTALLQLY DASNSEWQLG KTKVFLRESL EQKLEKRQEE EVTRAAMVIR AHVLGYLARK QYKKVLDCVV IIQKNYRAFL LRRRFLHLKK AAVVFQKQLR  800
                                           coiled coil
hum  GQIARRVYRQ LLAEKREQEE KKKQEEEEKK KREEEERERE RERREAELRA QQEEETRKQQ ELEAL.QKSQ KEAELTRELE KQKENKQVEE ILRLEKEIED  899
bov  GQIARRVYRQ LLAEKRAEEE KRKREEEEKR KREEEERERE RERREAELRA QQEEAARKQR ELEALQQESQ RAAELSRELE KQKENKQVEE ILRLEKEIED  900
                                                                                             PEST1
hum  LQRMKEQQEL SLTEASLQKL QERRDQELRR LEEEACRAAQ EFLESLNFDE IDECVRNIER SLSVGSEFSS ELAESACEEK PNFNFSQPYP .EEEVDEGFE  998
bov  LQRMKERQEL SLTEASLQKL QQLRDEELRR LEDEACRAAQ EFLESLNFDE IDECVRNIER SLSVGSGCTG E..QGAGAEK PSFNFSQPYP EEEEVDEGFE  998
                            PEST2                                            PEST3
hum  ADDDAFKDSP NPSEHGHSDQ RTSGIRTSDD SSEEDPYMND TVVPTSPSAD STVLLAPSVQ DSGSLHNSSS GESTYCMPQN AGDLPSPDGD YDYDQDDYED  1098
bov  ADDDAFKDSP NPSEHGHSDQ RTSGIRTSDE SSEEDPYMND TVVPTSPSAD STVLLAPSE. .....HDSSA GEPTYCLPQT PGALPAPEGD YDYDQDDYED  1092
                                                                                       PH1a
hum  GAITSGSSVT FSNSYGSQWS PDYRCSVGTY NSSGAYRFSS EGAQSSFEDS EEDFDSRFDT DDELSYRRDS VYSCVTLPYF HSFLYMKGGL MNSWKRRWCV  1198
bov  GAITSGSSVT FSNSCSSQWS PDYRCSVGTY NSSGAYRFSS EGAQSSFEDS EEDFDSRFDT DDELSYRRDS VYSCVTLPYF HSFLYMKGGL MNSWKRRWCV  1192
                   PH2
hum  LKDETFLWFR SKQEALKQGW LHKKGGGSST LSRRNWKKRW FVLRQSKLMY FENDSEEKLK GTVEVRTAKE IIDNTTKENG IDIIMADRTF HLIAESPEDA  1298
bov  LKDETFLWFR SKQEALKQGW LHKKGGGSST LSRRNWKKRW FVLRQAKLMY FENDSEEKLK GTVEVRAAKE IIDNTSKENG IDIIMADRTF HLIAESPEDA  1292
                                         PH1b                                                              PH3
hum  SQWFSVLSQV HASTDQEIQE MHDEQANPQN AVGTLDVGLI DSVCASDSPD RPNSFVIITA NRVLHCNADT PEEMHHWITL LQRSKGDTRV EGQEFIVRGW  1398
bov  SQWFSVLSQV HASTDQEIRE MHDEQANPQN AVGTLDVGLI DSVCASDSPD RPNSFVIITA NRVLHCNADT PEEMHHWITL LQRSKGDTRV EGQEFIVRGW  1392
hum  LHKEVKNSPK MSSLKLKKRW FVLTHNSLDY YKSSEKNALK LGTLVLNSLC SVVPPDEKIF KETGYWNVTV YGRKHCYRLY TKLLNEATRW SSAIQNVTDT  1498
bov  LHKEVKNSPK MSSLKLKKRW FVLTHNSLDY YKSSEKNALK LGTLVLNSLC SVVPPDEKIF KETGYWNVTV YGRKHCYRLY TKLLNEATRW SSAIQNVTDT  1492
                                                            MyTH4
hum  KAPIDTPTQQ LIQDIKENCL NSDVVEQIYK RNPILRYTHH PLHSPLLPLP YGDINLNLLK DKGYTTLQDE AIKIFNSLQQ LESMSDPIPI IQGILQTGHD  1598
bov  KAPIDTPTQQ LIQDIKENCL NSDVVEQIYK RNPILRHTHH PLHSPLLPLP YGDINLNLLK DKGYTTLQDE AIKIFNSLQQ LESMSDPIPI IQGILQTGHD  1592
hum  LRPLRDELYC QLIKQTNKVP HPGSVGNLYS WQILTCLSCT FLPSRGILKY LKFHLKRIRE QFPGTEMEKY ALFTYESLKK TKCREFVPSR DEIEALIHRQ  1698
bov  LRPLRDELYC QLIKQTNKVP HPGSVGNLCS WQILTCLSCT FLPSRGILKY LKFHLRRIRE QFPGTEMEKY ALFIYESLKK TKCREFVPSR DEIEALIHRQ  1692
                                                                               FERM
hum  EMTSTVYCHG GGSCKITINS HTTAGEVVEK LIRGLAMEDS RNMFALFEYN GHVDKAIESR TVVADVLAKF EKLAATSEVG DLPWKFYFKL YCFLDTDNVP  1798
bov  EMTSTVHCHG GGSCKITVNS HTTAGEVVEK LIRGLAMEDS RNMFALFEYN GHVDKAIESR TIVADVLAKF EKLAATSEVG EQPWKFYFKL YCFLDTDNVP  1792
hum  KDSVEFAFMF EQAHEAVIHG HHPAPEENLQ VLAALRLQYL QGDYTLHAAI PPLEEVYSLQ RLKARISQST KTFTPCERLE KRRTSFLEGT LRRSFRTGSV  1898
bov  KDSVEFAFMF EQAHEAVIHG HYPAPEENLQ VLAALRLQYL QGDYAPHAPV PPLEEVYSLQ RLKARISQST KSFTPGERLE KRRTSFLEGT LRRSFRTGSA  1892
hum  VRQKVEEEQM LDMWIKEEVS SARASIIDKW RKFQGMNQEQ AMAKYMALIK EWPGYGSTLF DVECKEGGFP QELWLGVSAD AVSVYKRGEG RPLEVFQYEH  1998
bov  IRQKAEEEQM VDMWVKEEVC SARASILDKW KKFQGMSQEQ AMAKYMALIK EWPGYGSTLF DVECKEGGFP QDLWLGVSAD AVSVYKRGEG RPLEVFQYEH  1992
hum  ILSFGAPLAN TYKIVVDERE LLFETSEVVD VAKLMKAYIS MIVKKRYSTT RSASSQGSSR 2058
bov  ILSFGAPLAN TYKIVVDERE LLFETSEVVD VAKLMKAYIS MIVKKRYSTS RSVSSQGSSR 2052
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accession #AW078286 and AI601763). Although apparently
ubiquitous in vertebrates, class X myosins have not been
identified in the complete genomes of S. cerevesiae, C. elegans,
or Drosophila. We thus conclude that myosin-X is most likely
a vertebrate-specific unconventional myosin.
Structure of myosin-X
Head and neck domains
The head domain (bovine aa 1-739) shares 35% sequence
identity with the head domain of human skeletal muscle
myosin and is most similar (45% identity) to human myosin-
VIIa, the gene that is mutated in Usher syndrome type Ib (Chen
et al., 1996). Myosin-X is not regulated by phosphorylation at
the ‘TEDS Rule’ site as it contains an acidic residue (Glu383)
instead of serine or threonine at this site (Bement and
Mooseker, 1995). Immediately following the head domain is a
neck domain consisting of 3 IQ motifs of approx. 24 aa each.
Since IQ motifs provide binding sites for calmodulin or
calmodulin-like proteins (Cheney and Mooseker, 1992), we
predict that each myosin-X heavy chain is associated with three
calmodulin or calmodulin-like light chains.
Tail domains
Coiled coil and a PEST region associated with calpain
cleavage
Beyond the IQ motifs is a region predicted to form a coiled
coil of 10-20 nm in length (Berger, 1995; Lupas et al., 1991),
raising the strong possibility that myosin-X heavy chains
form dimers. Between aa 979 and 1115 are three PEST
regions, which are enriched in proline, glutamate, serine and
threonine and are associated with susceptibility to cleavage
by proteases such as the calcium-dependent protease calpain
(Rechsteiner and Rogers, 1996). Cleavage of myosin-X at the
PEST sites would sever the motor domain from the distal tail
domains.
Three pleckstrin homology domains
The most unique feature of the myosin-X sequence is the
complex of three pleckstrin homology (PH) domains found
from aa 1168 to 1491 (Fig. 3A). The PH domains in myosin-
X have an unusual organization in that the first PH domain
(PH1) is split by the insertion of the second PH domain (PH2)
(Fig. 3A,B). This insertion occurs precisely at the site of a
highly variable surface loop where other PH domains have also
b en reported to contain large insertions (Macias et al., 1994;
Musacchio et al., 1993). As a result, the two halves of PH1
receive low probability scores individually, but when pieced
together PH1 is easily identified by web-based scanning
algorithms such as Pfam (Bateman et al., 2000).
PH1 and PH2 are most similar to the PH domain in
Dictyosteliumprotein kinase B homologs, but the C-terminal
half of the third PH domain (PH3) is not well conserved and
lacks significant homology to other known PH domains.
Sequence analysis (Fig. 3C) indicates that myosin-X PH2 and
PH3 contain several residues conserved in other proteins that
bind phosphatidylinositol lipids phosphorylated at the 3-
position through the action of phosphatidylinositol-3-kinase
(PI3K) (Isakoff et al., 1998; Rameh et al., 1997).
A MyTH4 and a FERM domain similar to several
different myosins and a kinesin
The myosin-X tail also contains an intriguing region of
approximately 150 aa (the myosin tail homology 4, or MyTH4
domain) that shares similarity with the tail domains of myosins
from several other classes and a plant kinesin protein. The core
conserved region of the myosin-X MyTH4 domain is ~26%
identical to other MyTH4 domains such as those found in
myosin-VIIa (Chen et al., 1996) and myosin-XV (Wang et al.,
1998), both of which are associated with hereditary deafness
n humans and mice. Remarkably, the kinesin-like calmodulin
binding protein (Reddy et al., 1996), a microtubule-based
1a 1168 TLPYFHSFLYMKGGLMNS.....WKRRWCVLKDETFLWFRSK 
2  1205 QEALKQGWLHKKGGGSSTLSRRNWKKRWFVLRQAKLMYFENDSEEKLK.GTVEVRAAKEII...DNTSKENG...IDIIMADRTFHLIAESPEDASQWFSVLSQV.
1b 1325                                            GTLDVGLIDSVCASDSPDRPNS..........FVIITANRVLHCNADTPEEMHHWITLLQRSK  






M-X PH 1a 1172 FHSFLYMKGGLMNS.....WKRRWCVLK
M-X PH 2  1209 KQGWLHKKGGGSSTLSRRNWKKRWFVLR
M-X PH 3  1389 VRGWLHKEVKNSPKMSSLKLKKRWFVLT
Akt/PKB        KEGWLHKRGEYIKT.....WRPRYFLLK
Btk            LESIFLKRSQQKKKTSPLNFKKRLFLLT
Grp-1/ARNO     REGWLLKLGGRVKT.....WKRRWFILT
DAPP1          KEGYLTKQGGLVKT.....WKTRWFTLQ
PLC-gamma      MTLFYSKKSQR........PERKTFQVK
β1    loop    β2 
Fig. 3. The PH domain complex of myosin-X. (A) Alignment of the bovine myosin-X PH domains indicates that PH1 is relatively well
conserved despite the insertion of PH2 into a variable loop region, while PH3 is the least conserved. (B) The organization of PH domains in
myosin-X is unique in that the second PH domain is inserted between two halves of the first PH domain. (C) Myosin-X PH domains 2 and 3
contain a number of residues within the β1-loop-β2 region present in other PH domains that have been demonstrated to bind PI3K products.
This region has previously been hypothesized to play an important role in mediating binding to PI(3,4)P2 or PI(3,4,5)P3 (Isakoff et al., 1998;
Rameh et al., 1997). Conserved residues identified by Isakoff et al., are indicated in bold, and charged residues in the loop are underlined.
(GenBank accession #s: Mouse Akt/PKB – X65687, Mouse Btk – L29788, Mouse GRP1 – AF001871, Human ARNO – X99753, Mouse
DAPP1 – AF163255, Human PLC gamma – M34667.)
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motor from plants, also contains a MyTH4 domain. A full
alignment of MyTH4 domains has been published recently
(Liang et al., 1999).
The carboxyl terminal end of the myosin-X tail contains a
region of 250-300 aa known as the FERM domain (Chishti et
al., 1998), found in Band 4.1-like proteins and the N-terminal
portion of ezrin/radixin/moesin. Although FERM domains
exhibit relatively low overall protein sequence identity with
one another (roughly 20-50% identity between different
protein families), these domains have been identified in a
large number of proteins, including talin, merlin (the
neurofibromatosis 2 gene), and certain tyrosine phosphatases.
Other motor proteins with FERM domains include myosin-
VIIa, myosin-XV, and the kinesin-like calmodulin binding
protein.
Myosin-X mRNA is widely expressed in vertebrate
tissues
In order to determine the tissue distribution of this novel
myosin, we probed a human multiple tissue northern blot and
human master blot under stringent hybridization conditions
with a 1 kb segment of human myosin-X cDNA corresponding
largely to 3′ untranslated sequence (Fig. 4). By northern
analysis, human myosin-X is widely distributed and has a
primary mRNA transcript of approx. 9.2 kb in most tissues
(Fig. 4A). Interestingly, the predominant transcript in human
brain was only 6.0-6.9 kb. A northern blot from rat
demonstrated that the myosin-X transcript in rat brain was also
smaller than in other tissues (not shown). The human RNA dot
blot (Fig. 4B) indicates that myosin-X is nearly ubiquitous in
the represented tissues. The same samples, when probed for
myosin-Va, resulted in a dramatically different distribution
(O. Rodriguez, personal communication) and when probed for
ubiquitin demonstrated equal loading of all samples (not
shown). High levels of myosin-X mRNA expression were
detected in kidney, testis, ovary, pancreas, pituitary gland,
thyroid gland, liver, lung, stomach, small intestine, colon,
placenta, and most regions of the brain. Moderate levels of
myosin-X expression were detected in prostate, adrenal gland,
salivary gland, mammary gland, spleen, and trachea. Myosin-
X message was relatively low in muscular tissues such as heart,
aorta, skeletal muscle, bladder, and uterus; expression was also
limited in hematopoietic/immune tissues such as bone marrow,
thymus, peripheral leukocytes, and lymph nodes. While these
data suggest that myosin-X expression is relatively higher in
some tissues than in others, it is clear that myosin-X mRNA is
present to some degree in virtually all tissues sampled.
To examine which cell types express myosin-X mRNA, we
performed in situ hybridizations on adult mouse brain and
testis sections using mouse myosin-X antisense and control
sense RNA probes (Fig. 5). The most intense staining in
brain was detected in cerebellar Purkinje cells, where myosin-
X mRNA was localized to the cell body and proximal
dendrites. In testis, myosin-X staining was most intense in a
circumferential distribution around the basal aspect of the
seminiferous tubule. This staining pattern is consistent with
localization in Sertoli cells, which are supporting cells that
partially envelop the developing germ cells by way of a
specialized cell-cell junction known as the ectoplasmic
specialization, which consists of microtubules, endoplasmic
reticulum, and f-actin (Grove and Vogl, 1989).
Myosin-X protein expression in tissues and cells
Since nothing was previously known about the distribution and
biochemical properties of class X myosins, we raised specific
antibodies against the head and tail of myosin-X (Fig. 1C). In
immunoblots of cultured MDBK cells, both antibodies detect
a ~235 kDa band (Fig. 6A, lanes 1 and 2) that is clearly of
higher molecular mass than myosin-II (Fig. 6A, lane 3),
suggesting that this band is indeed the full-length myosin-X.
In bovine tissues, myosin-X antibodies detect a ~235 kDa band
that appears to be most abundant in kidney and testis, less
abundant in liver, and below the detection threshold in lung
(Fig. 6B). Note that in bovine brain, antibodies to the myosin-
X head (Fig. 6B, lanes 5 and 6) or tail (Fig. 6B, lanes 7 and 8)
both detect a smaller band of ~180 kDa, indicating that the
smaller mRNA transcript detected in brain northern blots is
likely to be an alternate splice form that encodes a truncated
protein. Interestingly, cerebellum appears to express both full-
length and smaller myosin-X isoforms, while other regions of
the brain express primarily the ~180 kDa form.
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Fig. 4. (A) High stringency
northern blot of human
mRNA probed for myosin-
X. A ~9.2 kb myosin-X
transcript is detected in
most tissues, although a
smaller transcript of 6.0-
6.9 kb exists in brain.
(B) Dot-blot of human
mRNA. Myosin-X is
virtually ubiquitous in the
sampled tissues. 
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To assess the approximate abundance of myosin-X, we used
the ~130 kDa baculovirus-expressed head/neck/coiled coil
fragment as a standard for semi-quantitative immunoblotting.
This leads to the estimate that myosin-X comprises ~0.0005%
of total kidney protein (not shown). In comparison, myosin-Va
is thought to represent ~0.1-0.5% of the protein in brain.
Similar experiments in confluent cultures of MDBK cells led
to the estimate that MDBK cells contain several hundred
molecules of myosin-X per cell. It is important to note,
however, that sub-confluent MDBK cultures contain cells
that appear 5- or 10-fold brighter than others by
immunofluorescence (see below), so the actual number of
myosin-X molecules may be higher in some cells than others.
Nevertheless, although myosin-X is widely expressed in a
variety of vertebrate tissues, it is clearly less abundant than
myosin-II, myosin-V, or myosin-VI.
Subcellular fractionation indicates that myosin-X
exists in both soluble and insoluble pools
An obvious question is whether myosin-X is
soluble or associated with insoluble structures such
the cytoskeleton, plasma membrane, or organelles.
In subcellular fractionation experiments with
kidney, much of the myosin-X pelleted at 10,000
g, although a significant portion remained soluble
at 100,000 g (Fig. 6C). Whereas addition of ATP
or latrunculin to kidney homogenates did not
solubilize additional myosin-X, ATP in
combination with nonionic detergents such as
Triton X-100 or CHAPS increased the solubility of
myosin-X (not shown). Thus, the insoluble pool of
myosin-X was insensitive to treatments that
disrupt interactions with the actin cytoskeleton but
required additional disruption of membranes to
become soluble.
Myosin-X is a substrate for cleavage by
calpain
In initial immunoblots, several bands of lower
molecular mass were detected that appeared to be
associated with proteolytic breakdown of myosin-
X. Additionally, the presence of three PEST sites
in the tail provided potential sites for cleavage by
the calcium-activated protease, calpain, so we
tested whether myosin-X is indeed a substrate for
calpain. Kidney homogenates incubated in the
absence of calpain (Fig. 6D, lanes 1-4) accumulated
breakdown products over the time course studied,
while kidney homogenates incubated with calpain
(Fig. 6D, lanes 5-8) underwent significant
proteolysis almost immediately (lane 5), resulting
in an identical pattern of breakdown products. The
myosin-X head antibody detected three distinct
breakdown bands of approximately 123 kDa, 118
kDa and 103 kDa, which correspond well to the
predicted sizes of head domain-containing
fragments if myosin-X were cleaved at the three
PEST sites following the coiled coil region. Other
proteins such as myosin-II remained unaffected by
calpain digest as visualized by immunoblotting (not
shown). Thus, myosin-X is clearly an excellent
substrate for calpain in vitro. These results account for the
putative breakdown fragments sometimes seen on immunoblots
(Fig. 6C,E) and they may explain the relatively low amount of
myosin-X protein present in tissues and cells.
Myosin-X cosediments with f-actin in an ATP-
sensitive manner
One property expected of a myosin is the ability to bind f-actin
in an ATP-sensitive manner. We thus performed f-actin
cosedimentation assays using soluble myosin-X from cell
lysates in the presence and absence of ATP (Fig. 6E). Soluble
myosin-X present in a high speed supernatant from MDBK
cells homogenized in the presence of 0.5 mM ATP did not
significantly cosediment with f-actin. However, when the
samples were treated with hexokinase and glucose to deplete
the lysate of ATP (Pollard et al., 1978), the majority of myosin-
X was detected in the actin pellet (lane 9), indicating that
myosin-X can bind to actin either directly or indirectly in an
ATP-sensitive fashion. 
Fig. 5. In situ hybridization in mouse cerebellum (A-D) and testis (E-F). Antisense
probe (A,C,E) detects myosin-X message in large cells of the mouse cerebellum
corresponding to the characteristic pattern of Purkinje cells (A). At higher
magnification, myosin-X mRNA is present throughout the cell body of the Purkinje
cells (B). In mouse testis, myosin-X is detected around the perimeter of the testicular
cords with occasional extension toward the lumen (E), characteristic of the Sertoli
cells that surround and nurture developing germ cells. Sense control probe (B,D,F)
confirms the specificity of the localization. Bars, 100 µm (A,B); 50 µm (C-F).
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Myosin-X associates with regions of dynamic actin
in cultured cells
To elucidate possible functions of this novel motor protein, we
used MDBK cells as a model system for subcellular
localization. We used a bovine cell line because both the head
and tail antibodies react specifically with bovine myosin-X in
immunoblots. In these cells, myosin-X protein is present in
membrane ruffles (Fig. 7A-C), puncta at the edge of the
lamellipodium (Fig. 7D-F) and/or intensely along the
lamellipodium (Fig. 7G-I). Note, however, that much of the
fluorescence intensity is also distributed in small, diffuse
puncta throughout the cell, often with perinuclear
concentration. Using the x-z scanning capability of the
confocal microscope, it is clear that myosin-X colocalizes
precisely with f-actin at the edge of the lamellipodium and
within ruffles (Fig. 7H, 1-3) and that many of the myosin-X
puncta are cytoplasmic while others are closer to the plasma
membrane (Fig. 7G, 1-3). The nature of the cytoplasmic puncta
is thus far unknown. Antibodies to the myosin-X tail also
stain membrane ruffles and lamellipodia prominently with
additional cytoplasmic punctate staining, highly similar to the
pattern detected by the head antibody (not shown).
Cells that are brightly stained for myosin-X tend to exhibit
hallmarks of motility such as actin-rich membrane ruffles. In
cells with less myosin-X immunoreactivity, staining is still
detected in cytoplasmic puncta and at the edge of the
lamellipodium. Strikingly, myosin-X is often detected at the
outer tips of spoke-like bundles of f-actin within the lamella
(Fig. 7D-F). These actin bundles were not associated with
vinculin staining (not shown), indicating that they are not
mature stress fibers, though they may represent nascent stress
fibers with early focal complexes at their tips. It is also possible
that these bundles are filopodia that have not extended beyond
the margin of the cell, since myosin-X immunoreactivity is also
seen in relatively rare filopodial processes in MDBK cells.
Intense myosin-X staining is particularly evident in
subconfluent cultures, where 25-30% of MDBK cells are
highly immunoreactive for myosin-X, while other cells contain





(A) Antibodies to the
myosin-X head (lane
1) and tail (lane 2)
both detect a ~235
kDa band between the
α– and β–spectrin
standards at 240 kDa
and 220 kDa on
immunoblots of
MDBK cell lysates.
(B) The highest levels
of myosin-X protein
expression were
detected in bovine kidney (lane 1) and testis (lane 2), with
less in liver (lane 3) and undetectable levels in lung (lane
4). In bovine cerebellum (lane 5), bands of ~235 kDa and
~180 kDa were detected, while in cerebral cortex (lane 6)
the ~180 kDa form predominated. The ~180 kDa form is
detected by both the head (lanes 5 and 6) and tail (lanes 7
and 8) antibodies. (C) Myosin-X in kidney homogenates
is present in both soluble and insoluble pools. A large
portion of myosin-X in kidney homogenates subjected to
sequential centrifugation was found in the 10,000 g pellet
(lane 4), although some myosin-X remained soluble at
100,000 g (lane 5). (D) Proteolytic breakdown of myosin-
X in kidney homogenates. Kidney homogenates were
incubated in the absence (lanes 1-4) or presence of
calpain (lanes 5-8) for the indicated times (in minutes)
after which proteolysis was halted by the addition of
EGTA. At t0 (lane 5) calpain was added and the reaction
was quenched as quickly as possible. The myosin-X head
antibody detected bands of ~123 kDa, ~118 kDa and
~103 kDa, the expected sizes of motor domain fragments
following cleavage at the PEST sites. A ~30 kDa
fragment detected by the head antibody may represent a small motor domain antigen that was resistant to proteolysis. (E) Myosin-X from cell
lysates cosediments with actin. The 150,000 g supernatant (lane 2) and pellet (lane 3) from MDBK cells homogenized in buffer containing 0.5
mM ATP each contained roughly half of the myosin-X. A portion of the supernatant was then incubated with f-actin in the absence or presence
of hexokinase and glucose to deplete the ATP. Samples of untreated supernatant (lanes 4 and 5), supernatant plus actin alone (lanes 6 and 7),
and supernatant plus actin, hexokinase, and glucose (lanes 8 and 9) were then centrifuged at 150,000 g to obtain a second supernatant and
pellet. As expected for a myosin, a significant amount of myosin-X co-precipitated with actin after removal of ATP (lane 9).
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only background levels of staining. In highly confluent
cultures, myosin-X staining intensity is lower, more uniform,
and restricted largely to diffuse cytoplasmic puncta. By
confocal x-z scanning, myosin-X in confluent MDBK cells is
present throughout the volume of the cell, although
occasionally prominent at the apical and/or basal margins, and
absent from cell-cell junctions (not shown).
Although the data here illustrate myosin-X localization in
MDBK cells, we have also examined other cell-types,
including cow pulmonary artery endothelial (CPAE) cells,
human cervical cancer (HeLa) cells, human embryonal kidney
(HEK293) cells, and primary rat glia and neurons (not shown).
The staining pattern in each of these cells was consistent with
that seen in MDBK cells, but varied somewhat depending on
the cell type. In CPAE and HeLa cells, staining of lamellipodia
and the tips of filopodia-like processes was particularly
prominent. In HEK293 cells myosin-X localized in
cytoplasmic puncta, within filopodia, and at foci of actin
around the peripery of the cell. Rat glia exhibited cytoplasmic
puncta, filopodial staining, and a distribution along actin
bundles within the broad lamellipodia and cell body. In primary
cultured neurons, myosin-X was present in growth cones along
filopodial extensions. These results confirm that the overall
myosin-X staining pattern consists of several main
components: diffuse cytoplasmic puncta, intense staining of
membrane ruffles and lamellipodia, and distinct puncta at the
Fig. 7. Myosin-X associates with
membrane ruffles, lamellipodia,
and puncta at the tips of filopodia-
like actin bundles. Specific
antibodies to the myosin-X head
domain were used to localize
endogenous myosin-X (A,D,G) by
confocal microscopy. Actin was
stained using rhodamine phalloidin
(C,F,I). In a brightly stained cell
(A-C), myosin-X colocalized with
f-actin in membrane ruffles at the
leading edge. Myosin-X also
localized to diffuse puncta
throughout the cell. In a less
immunoreactive cell without
dramatic membrane ruffles (D-F),
myosin-X immunoreactivity was
present at the tips of spoke-like
bundles of f-actin extending to the
edge of the lamellipodium. In a
moderately immunoreactive
MDBK cell (G-I), myosin-X
colocalized with f-actin along the
edge of the lamellipodium (arrow
1) as well as at sites of membrane
ruffling (arrow 2). Numbered
arrows refer to the approximate
locations of confocal x-z scans
taken through the cell. Confocal x-
z scans through the lamellipodium
(G1,H1,I1) and a region of the cell
containing membrane ruffles
(G2,H2,I2) confirms that myosin-
X colocalized with actin in these
regions. An x-z scan through a
region of the cell containing the
nucleus (G3,H3,I3) indicates that
the diffuse puncta of myosin-X
were distributed within the
cytoplasm as well as at the plasma
membrane. Bars: 10 µm (A-F); 25
µm (G-I).
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tips of filopodia-like actin bundles. However, the precise
staining pattern can vary within a population of cells and may
depend to a certain extent on the particular morphology of
different cell types.
Myosin-X distribution is dynamic and does not rely
entirely on actin 
To further examine the association of myosin-X protein with
regions of actin dynamics, we carried out mechanical and
pharmacological perturbations of MDBK cells. Since myosin-
X is largely restricted to cytoplasmic puncta in confluent cells,
we wounded a confluent monolayer to determine if myosin-X
redistributes to regions undergoing actin dynamics. As
expected, myosin-X localized to ruffles and filopodia in cells
along the edge of the wounded monolayer within 30 minutes
of wounding (not shown). Next, we trypsinized and replated
cells to determine the localization of myosin-X during cell
spreading (Fig. 8). In small round cells, myosin-X was present
in distinct puncta at the tips of processes extending from the
cell body (Fig. 8A). Using confocal microscopy, we observed
that these filopodia-like processes extended from all regions of
the cell body, including areas not in contact with the substrate.
As the cells began to spread, myosin-X was present in
membrane ruffles (Fig. 8B), at the edge of lamellipodia (Fig.
8C), and later to a polarized distribution at the presumptive
leading edge of the cell (Fig. 8D). Thus, it is clear that the
distribution of myosin-X can be dynamic, depending on the
state of motility observed in cultured cells.
Treatment of MDBK cells with cytochalasin-D (Fig. 8E-H)
or latrunculin (not shown), both of which alter the actin
cytoskeleton, abolished actin-rich lamellipodia and membrane
ruffles and therefore myosin-X localization in such structures.
In these cells, myosin-X staining was apparent in bright puncta
at the tips of processes that appear to have resulted from
retraction of membranes from foci of adhesion. This pattern of
staining was remarkably similar to the puncta detected at the
tips of actin bundles in some untreated cells (see Fig. 7D-F),
and indicates that localization of myosin-X to regions of
dynamic actin is not dependent solely on actin.
DISCUSSION
We report the discovery and initial characterization of myosin-
X, the founding member of a novel class of myosins
characterized by a unique tail structure with three pleckstrin
homology domains. Myosin-X is widely expressed in
vertebrate tissues, though apparently less abundantly than
several other myosins. The tail domain structure, biochemical
data, and localization results that we have presented suggest a
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Fig. 8. Myosin-X localizes to regions of actin dynamics in spreading cells and remains associated with similar structures in the absence of f-
actin. MDBK cells were trypsinized and replated for 1-2 hours (A-D). Representative examples of cells fixed in different stages of spreading
and imaged by epifluorescence microscopy are shown. (A) Small, round cells exhibited puncta of myosin-X at the tips of processes extending
from the cell body. These processes may represent filopodia or adhesive processes. (B) Myosin-X localized to membrane ruffles around th
periphery and to bright puncta within the center of a spreading cell. (C) Myosin-X was associated with lamellipodia and diffuse puncta in cells
of nearly full size. (D) Myosin-X staining became polarized to the leading edge in cells that appear to be undergoing motility. (E-H) Confocal
extended-focus images of MDBK cells treated with cytochalasin-D exhibit myosin-X staining (E,G) at the tips of processes similar to the tips
of filopodia. These structures lack a significant amount of f-actin (F,H), although some stress fibers in the cell body survive cytochalasin-D
treatment. Bars, 25 µm.
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role for myosin-X in regions of dynamic actin. As illustrated
in the model we propose in Fig. 9, if myosin-X exists as a
dimer, as suggested by the presence of a coiled coil domain,
then as many as six PH domains, two MyTH4 domains, and
two FERM domains could be exposed for interactions with
membrane phospholipids or other proteins, thus allowing
assembly of a large molecular complex.
Structure and function of myosin-X
Although the myosin-X motor domain is only 35% identical to
the motor domain of myosin-II, conserved sequences within
this region suggest that myosin-X can in fact operate as
an actin-based motor. We have demonstrated that soluble
myosin-X sediments with f-actin in an ATP-sensitive fashion,
consistent with the properties of other myosins. In addition,
recent evidence indicates that a baculovirus-expressed myosin-
X head domain in fact functions as an actin-based motor (Chen
et al., 1999). However, since myosin-X remains at the tips
of adhesion-like processes in cells following treatment with
cytochalasin-D, the interaction of myosin-X with these
structures may not depend entirely on actin. Instead, the
myosin-X tail domains (the PH domains, MyTH4 and/or
FERM domain) could be at least partially responsible for its
localization. Furthermore, the observation that myosin-X
immunoreactivity varies within a population of cells is
consistent with the possibility of proteolysis at the PEST sites,
since we have shown that myosin-X is an excellent substrate
for calpain in vitro.
Interestingly, it appears that there may be non-motor
proteins whose structures would resemble a distal tail fragment
of myosin-X resulting from cleavage at a PEST site. A partial
cDNA sequence from human brain (KIAA1200; accession
#BAA86514) is predicted to contain two PH domains, a
MyTH4 domain, and a FERM domain with approx. 25%
identity to myosin-X along the corresponding part of the
myosin-X tail. Previously undescribed putative proteins from
genomic sequences of Drosophila melanogaster(accession
#AL031583) and C. elegans(accession #Z78059) also share
structural similarity to the myosin-X tail and KIAA1200,
despite the absence of class X myosins in these organisms. It
therefore appears that the combination of PH, MyTH4, and
FERM domains found in the myosin-X tail may have a novel
functional relationship with each other, distinct from the
identity of myosin-X as a molecular motor.
Until the discovery of the MyTH4 domain (Chen et al.,
1996), it was generally believed that there was little or no
similarity in the tails of myosins from different classes
except for the existence of SH3 domains in certain class I
and class IV myosins and the presence of coiled coil
structure in many other myosins. As reviewed elsewhere, a
number of unconventional myosins including myosin-X
contain MyTH4 and FERM domains (Oliver et al., 1999).
While the functions of these shared domains are still largely
unknown, their presence in the tail domains of otherwise
different motors raises the possibility of a shared system for
docking and/or regulation. Biochemical evidence from other
FERM domain-containing proteins indicates that this
domain may be particularly important for binding to integral
membrane proteins such as CD44, ICAM-1, -2, and –3, and
CD43 (Tsukita and Yonemura, 1999), suggesting a
mechanism by which myosin-X could be targeted to the
actin-membrane interface. Consistent with this possibility,
we have shown that a significant portion of myosin-X
remains insoluble despite treatments that perturb the actin
cytoskeleton.
Although many proteins contain one or two PH domains,
myosin-X is somewhat unusual in that it contains three PH
domains, one of which is split by the insertion of another.
Myosin-X does not appear closely related to Dictyostelium
MyoM, a recently discovered unconventional myosin whose
tail domain contains a single PH domain and a Dbl homology
domain (Schwarz et al., 1999). Although the PH domains
found in MyoM and a member of the kinesin family of
microtubule motors, Unc104/Kif1a (Ponting, 1995), are not
closely related to those of myosin-X, the presence of PH
domains in actin-based and microtubule-based molecular
motors suggests the possibility that phospholipids may play a
general role in targeting and/or regulation of motors.
Most PH domains are now thought to bind with varying
degrees of specificity (Kavran et al., 1998; Rameh et al., 1997;
Salim et al., 1996) to membrane phospholipids such as PIP2,
now well known as a regulator of the actin cytoskeleton (Toker,
1998), and PI(3,4)P2 and PI(3,4,5)P3, which are second
messengers in phosphatidylinositol-3-kinase (PI3K) signaling
pathways important in numerous facets of cellular physiology
(Rameh and Cantley, 1999). Sequence analysis suggested that
myosin-X PH domains 2 and 3 may be able to bind PI(3,4)P2
or PI(3,4,5)P3 (Fig. 3C), and importantly, a modified yeast two-
hybrid assay was previously used to show that PH domain 2
from myosin-X can in fact bind to PI3K products (Isakoff et
al., 1998). There is also evidence that PH domains may be
involved in protein-protein interactions (Glaven et al., 1999;
FERM domain:
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or other proteases
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via ~20nm coiled coil
Fig. 9. Hypothetical model of two myosin-X heavy chains that
dimerize via coiled coil interactions. This model proposes that the
myosin-X dimer binds six light chains and contains ten potential
sites (six PH domains, two MyTH4 domains, and two FERM
domains) for interactions with proteins or membranes.
3450
Tanaka et al., 1999; Touhara et al., 1994; Yao et al., 1999),
suggesting more complex targeting and regulation of proteins
containing PH domains.
Localization, biochemistry, and possible functional
roles of myosin-X
Lamellipodia, membrane ruffles, and filopodia are protrusive
structures associated with actin-based motility at the leading
edge of motile cells (Lauffenburger and Horwitz, 1996;
Mitchison and Cramer, 1996). Numerous proteins associated
with cell motility or regulation of signaling have been localized
to these structures, including Arp2/3 (Welch et al., 1997),
coronin (Mishima and Nishida, 1999), and ARF6 (Song et al.,
1998). Interestingly, class I myosins in yeast localize to regions
of actin polarization (Anderson et al., 1998) and may be involved
in nucleation of actin through their interactions with members
of the WASP family (Evangelista et al., 2000; Lechler et al.,
2000), suggesting that myosins-I may be involved in actin
polymerization at the edge of the lamellipodium. Localization of
myosin-X to regions of dynamic actin may implicate it as a
candidate motor for similar processes at the leading edge. 
Of particular relevance to myosin-X function, it has been
reported that PIP2 and PI(3,4,5)P3 play signaling roles in
regions of dynamic actin (Honda et al., 1999; Zhou et al.,
1998), and PI3K signaling has been implicated in a number of
cellular functions (Rameh and Cantley, 1999) including
phagocytosis (Araki et al., 1996) and nerve growth cone
guidance (Ming et al., 1999). Still to be resolved is whether the
myosin-X PH domains serve to recruit myosin-X to a particular
site in response to phospholipid signaling or whether other
domains in the myosin-X tail target the protein to its
appropriate location and phosphatidylinositol phospholipids
regulate the function of myosin-X.
Although the mechanisms of actin dynamics at the cell
periphery are now becoming better understood, the roles of
actin-based motors in these processes are still unclear. We have
identified a novel myosin, widely expressed in vertebrate tissues,
which is a component of subcellular compartments associated
with dynamic actin. Although the precise role of myosin-X is
yet to be determined, the tail domain structure proposed to form
a multi-protein/phospholipid complex, the previous evidence
that PH domain 2 binds to products of PI3K (Isakoff et al., 1998),
and the localization of endogenous myosin-X to lamellipodia
and filopodia clearly implicates myosin-X at the interface
between the actin cytoskeleton and plasma membrane signalling
in regions of active actin dynamics.
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